About SS Innovations International, Inc.
https://ssinnovations.comSS Innovations International, Inc. develops surgical robotic systems. It also develops SSI Mantra, a surgical robotic system; SSI Mudra, a range of surgical instruments that supports in surgical procedures, including robotic cardiac surgery; SSI Maya, a robotic surgery platform; and OMNI 3D HD provides live 3D HD view of the surgical field in robotic surgery operating room.
CEO
Sudhir Prem Srivastava
Compensation Summary
(Year )
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2023-04-17 | Reverse | 1:10 |
ETFs Holding This Stock
Summary
Showing Top 2 of 2
Ratings Snapshot
Rating : D+
Price Target
About SS Innovations International, Inc.
https://ssinnovations.comSS Innovations International, Inc. develops surgical robotic systems. It also develops SSI Mantra, a surgical robotic system; SSI Mudra, a range of surgical instruments that supports in surgical procedures, including robotic cardiac surgery; SSI Maya, a robotic surgery platform; and OMNI 3D HD provides live 3D HD view of the surgical field in robotic surgery operating room.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $12.83M ▲ | $8M ▲ | $-3.72M ▼ | -28.98% ▼ | $-0.02 ▼ | $-1.4M ▼ |
| Q2-2025 | $10M ▲ | $5.82M ▼ | $-256.69K ▲ | -2.57% ▲ | $-0 ▲ | $574.2K ▲ |
| Q1-2025 | $5.12M ▼ | $7.01M ▼ | $-5.68M ▲ | -110.95% ▲ | $-0.03 ▲ | $-5.09M ▲ |
| Q4-2024 | $5.62M ▲ | $10.66M ▲ | $-7.45M ▼ | -132.51% ▼ | $-0.04 ▼ | $-7.2M ▼ |
| Q3-2024 | $4.39M | $5.52M | $-3.25M | -73.99% | $-0.04 | $-2.88M |
What's going well?
Revenue grew 28% in just one quarter, showing strong demand. Gross profit also increased slightly, which means the core product is still selling well.
What's concerning?
Costs are rising much faster than sales, and gross margins dropped sharply. The company posted a much bigger loss, and a large tax expense made things worse.
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $11.71M ▲ | $69.58M ▼ | $29.93M ▲ | $39.65M ▼ |
| Q2-2025 | $11.38M ▼ | $69.98M ▲ | $27.95M ▲ | $42.02M ▲ |
| Q1-2025 | $15.87M ▲ | $63.46M ▲ | $22.9M ▼ | $40.55M ▲ |
| Q4-2024 | $466.5K ▲ | $42.39M ▲ | $28.93M ▲ | $13.46M ▼ |
| Q3-2024 | $220.36K | $37.81M | $23.92M | $13.89M |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $-3.72M ▼ | $-7.47M ▼ | $-755.08K ▼ | $3.09M ▲ | $-5.57M ▼ | $-8.22M ▼ |
| Q2-2025 | $-256.69K ▲ | $-3.45M ▲ | $-316.65K ▲ | $-702.1K ▼ | $-4.47M ▼ | $-3.77M ▲ |
| Q1-2025 | $-5.68M ▼ | $-6.1M ▼ | $-872.8K ▼ | $22.41M ▲ | $15.46M ▲ | $-6.98M ▼ |
| Q4-2024 | $-1.92M ▲ | $-3.26M ▼ | $-125.14K ▼ | $3.41M ▲ | $524.52K ▲ | $-3.39M ▼ |
| Q3-2024 | $-3.25M | $-2.55M | $1.7M | $722.34K | $-447.88K | $-843.98K |
Revenue by Products
| Product | Q1-2025 | Q2-2025 | Q3-2025 |
|---|---|---|---|
 System Sales Member | $0 ▲ | $10.00M ▲ | $10.00M ▲ |
Revenue by Geography
| Region | Q2-2025 | Q3-2025 | Q1-2025 |
|---|---|---|---|
 INDIA | $10.00M ▲ | $10.00M ▲ | $0 ▼ |
 INDONESIA | $0 ▲ | $0 ▲ | $0 ▲ |
 IRAQ | $0 ▲ | $0 ▲ | $0 ▲ |
 NEPAL | $0 ▲ | $0 ▲ | $0 ▲ |
 PHILIPPINES | $0 ▲ | $0 ▲ | $0 ▲ |
 South America | $0 ▲ | $0 ▲ | $0 ▲ |
 UNITED ARAB EMIRATES | $0 ▲ | $0 ▲ | $0 ▲ |
CEO
Sudhir Prem Srivastava
Compensation Summary
(Year )
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2023-04-17 | Reverse | 1:10 |
ETFs Holding This Stock
Summary
Showing Top 2 of 2
Ratings Snapshot
Rating : D+